High expression of SALL4 is associated with poor prognosis in squamous cell carcinoma of the uterine cervix. 2018

Chunchan Di, and Jing Sun, and Hongwei Zhang, and Ping Zhou, and Jienan Kong
Department of Pathology, The First Hospital of Zibo Zibo, Shandong, China.

Background: The zinc-finger transcription factor Sal-like protein 4 (SALL4) plays a pivotal role in tumor invasion and metastasis. Here, we investigated the clinicopathological significance of SALL4 overexpression in cervical squamous cell carcinoma (SCC) of the uterine cervix. Methods: SALL4 immunohistochemical staining was performed on cervical SCC specimens from 129 patients, as well as 98 cases of cervical squamous intraepithelial lesion (LSIL and HSIL) and 29 normal cervix samples. SALL4 immunofluorescence staining was performed in CaSki and SiHa cervical cancer cells. Statistical analyses were applied to evaluate correlations between SALL4 overexpression and clinicopathological features of SCC patients. Survival rates were calculated using the Kaplan-Meier method, and relationships between prognostic factors and patient survival were analyzed using Cox proportional hazard models. Results: SALL4 protein showed mainly nuclear staining in cervical cancer cells. Strong diffuse SALL4 staining was frequently seen in cervical cancer compared with normal tissues. SALL4 expression was significantly higher in cervical cancers than in LSIL, HSIL, and normal cervical epithelia. SALL4 overexpression was positively correlated with poor differentiation, late-stage, and lymph node metastasis. Moreover, the 5-year survival rate of early-stage cervical cancer patients with high SALL4 expression was significantly lower than patients with low SALL4 expression. Multivariate analysis suggested that SALL4 protein expression is an independent risk factor for survival in SCC. Conclusions: SALL4 plays an important role in SCC progression. High-level SALL4 expression is an independent prognostic factor of poor outcomes in SCC.

UI MeSH Term Description Entries

Related Publications

Chunchan Di, and Jing Sun, and Hongwei Zhang, and Ping Zhou, and Jienan Kong
June 2014, BMC cancer,
Chunchan Di, and Jing Sun, and Hongwei Zhang, and Ping Zhou, and Jienan Kong
March 2014, Journal of oral pathology & medicine : official publication of the International Association of Oral Pathologists and the American Academy of Oral Pathology,
Chunchan Di, and Jing Sun, and Hongwei Zhang, and Ping Zhou, and Jienan Kong
February 1994, Cancer,
Chunchan Di, and Jing Sun, and Hongwei Zhang, and Ping Zhou, and Jienan Kong
November 2020, Oncology letters,
Chunchan Di, and Jing Sun, and Hongwei Zhang, and Ping Zhou, and Jienan Kong
September 2019, Medicine,
Chunchan Di, and Jing Sun, and Hongwei Zhang, and Ping Zhou, and Jienan Kong
April 2015, Diagnostic pathology,
Chunchan Di, and Jing Sun, and Hongwei Zhang, and Ping Zhou, and Jienan Kong
January 2013, International journal of clinical and experimental pathology,
Chunchan Di, and Jing Sun, and Hongwei Zhang, and Ping Zhou, and Jienan Kong
March 2018, Oncology letters,
Chunchan Di, and Jing Sun, and Hongwei Zhang, and Ping Zhou, and Jienan Kong
January 2018, International journal of clinical and experimental pathology,
Chunchan Di, and Jing Sun, and Hongwei Zhang, and Ping Zhou, and Jienan Kong
August 2016, Cancer chemotherapy and pharmacology,
Copied contents to your clipboard!